Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2017-07-21

FDA Approved: ZESTORETIC — Supplemental Application (Almatica Pharma Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ZESTORETIC (lisinopril and hydrochlorothiazide) by Almatica Pharma Inc., resulting in updated labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZESTORETIC (LISINOPRIL AND HYDROCHLOROTHIAZIDE)

Snippet

SUPPL AP for ZESTORETIC (LISINOPRIL AND HYDROCHLOROTHIAZIDE)